gsk.com is a domain that was created on 1998-08-07,making it 26 years ago. It has several subdomains, such as be.gsk.com my.gsk.com , among others.
Description:At GSK, we unite science, technology and talent to get ahead of disease...
Discover gsk.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
HomePage size: 187.992 KB |
Page Load Time: 0.351901 Seconds |
Website IP Address: 34.117.83.221 |
Homepage | GSK Help Center https://contactus.gsk.com/ |
GSK Careers Apply https://jobs.gsk.com/ |
GSK Value https://value.gsk.com/ |
Homepage | GSK Help Center for HCPs https://contactus.gsk.com/hcp/ |
GSK US Medical Affairs: Home https://www.usmedinfo.gsk.com/ |
Consumer Contact Form https://cecchat.gsk.com/ |
GlaxoSmithKline Pregnancy Registries https://pregnancyregistry.gsk.com/ |
GSK's Supported Studies Program https://iss.gsk.com/ |
AccessGSK Page https://digitaldelivery.gsk.com/ |
Home | GSK US https://us.gsk.com/en-us/home/ |
Products | GSK US https://us.gsk.com/en-us/products/ |
Company | GSK US https://us.gsk.com/en-us/company/ |
Home | GSK https://www.gsk.com/%E2%80%8E |
Products | GSK https://www.gsk.com/en-gb/products/ |
GSK at a glance | GSK https://www.gsk.com/en-gb/company/gsk-at-a-glance/ |
A gsk.com. 120 IN A 34.117.83.221 |
MX gsk.com. 2127 IN MX 5 mxa-001caa02.gslb.pphosted.com. |
NS gsk.com. 19984 IN NS ns-1070.awsdns-05.org. |
SOA gsk.com. 900 IN SOA ns-999.awsdns-60.net. awsdns-hostmaster.amazon.com. 1 7200 900 1209600 86400 |
Cache-Control: no-cache |
Pragma: no-cache |
Content-Type: text/html; charset=utf-8 |
Expires: -1,0 |
X-XSS-Protection: 1; mode=block |
X-Content-Type-Options: nosniff |
Access-Control-Allow-Origin: https://jobs.gsk.com |
Access-Control-Allow-Credentials: true |
Access-Control-Allow-Headers: Authorization |
X-Frame-Options: SAMEORIGIN |
Content-Security-Policy: "default-src self unsafe-eval unsafe-inline * data:; frame-ancestors self; frame-src self *", Date: Tue, 14 May 2024 02:56:22 GMT |
Content-Length: 274802 |
Via: 1.1 google |
Alt-Svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000 |
charset="utf-8"/ |
content="IE=edge" http-equiv="X-UA-Compatible"/ |
content="width=device-width, initial-scale=1" name="viewport"/ |
content="Home | GSK " property="og:title" |
content="website" property="og:type" |
content="https://www.gsk.com/en-gb/home/" property="og:url" |
content="At GSK, we unite science, technology and talent to get ahead of disease together" name="description"/ |
content="At GSK, we unite science, technology and talent to get ahead of disease together" property="og:description"/ |
content="https://www.gsk.com/assets/img/GSK_Logo_Full_Colour_RGB.png?mode=pad&width=350&height=157" name="image" property="og:image"/ |
content="400" property="og:image:width"/ |
content="300" property="og:image:height"/ |
content="summary_large_image" name="twitter:card"/ |
content="@gsk" name="twitter:site"/ |
content="Home | GSK" name="twitter:title"/ |
content="At GSK, we unite science, technology and talent to get ahead of disease together" name="twitter:description"/ |
content="https://www.gsk.com/assets/img/GSK_Logo_Full_Colour_RGB.png?mode=pad&width=350&height=157" name="twitter:image"/ |
content="Home" name="site-section" |
Ip Country: United States |
City Name: Kansas City |
Latitude: 39.1027 |
Longitude: -94.5778 |
Company Back to main Company Company Purpose, strategy and culture Outstanding people Company Outstanding people Working together My GSK story Innovating together 2022 Innovating together 2021 GSK at a glance History and heritage Board of directors and leadership team Board information Governance Company Governance Committees Shareholders Sarbanes-Oxley Act 2002 Compliance Policy positions Codes, standards and reports FEATURED SECTION Our purpose, strategy and culture FEATURED SECTION Outstanding peopleInnovation Back to main Innovation Innovation Research and development approach Pipeline Therapeutic areas Innovation Therapeutic areas Infectious diseases HIV Respiratory/immunology Oncology Technologies Clinical trials at GSK Innovation Clinical trials at GSK Provision of unlicensed medicines for unmet medical needs Data transparency Diversity in clinical trials Partnering with GSK Innovation Partnering with GSK Supported studies R&D locations SPOTLIGHT ON Behind the science magazine Featured section Partnering with GSKProducts Back to main Products Products Our product areas Products A-Z SPOTLIGHT ON Innovation FEATURED WEBSITE GSKPro for healthcare professionalsResponsibility Back to main Responsibility Responsibility Access Global health and health security Responsibility Global health and health security Global health Health security Using our science for global health Improving access to healthcare Environment Responsibility Environment Climate Freshwater Land Oceans Atmosphere Materials and waste Diversity, equity and inclusion Ethical standards Responsibility Ethical standards Working with third parties Public policy and patient advocacy Human rights Use of animals Engaging with healthcare professionals Product governance Charitable Investments ESG resources Responsibility ESG resources ESG reports archive FEATURED SECTION Diversity equity and inclusion SPOTLIGHT ON Our policy positionsInvestors Back to main Investors Investors Why invest in GSK? Quarterly results Financial reports Investors Financial reports Annual Report 2023 Corporate reports archive Environmental, social and governance Speeches and presentations Science publications Events calendar Dividend and share price Investors Dividend and share price GSK share price Share price calculators (GBp/USD) Dividend calculators (GBp/USD) Dividend calendar Analyst consensus Stock exchange announcements Investors Stock exchange announcements London (RNS) London (RNS) inside information New York (SEC) Sign up for announcements Shareholder information Investors Shareholder information Manage your shares Annual General Meeting General Meeting Annual Governance Meeting Corporate sponsored nominee service Our ADR programme Asset reunification - ProSearch Share scam alert Privacy notice for ordinary shareholders FAQs Corporate actions Investors Corporate actions Consumer Healthcare Demerger Consumer Healthcare Joint Venture Agreement to acquire TESARO Debt investors Feedback Investor contacts SPOTLIGHT ON Press releases SPOTLIGHT ON Our pipelineMedia Back to main Media Media Press releases Media contacts Conferences Media library Our response to the situation in Ukraine Our response to the crisis in Israel and Gaza Our social media RSS feeds FEATURED SECTION Behind the science magazine SPOTLIGHT ON ConferencesCareers Back to main Careers Careers Search jobs Featured careers Careers Featured careers A career in Data Life at GSK Careers Life at GSK What’s your angle? Experienced professionals Careers Experienced professionals Business Operations Engineering at GSK Manufacturing and supply Marketing and sales Research and development Experienced professionals Research and development Chemical Manufacturing and Controls (CMC), Medicine Development and Supply (MDS) Genomic sciences Technology Early talent Careers Early talent Kickstart your career Apprentice programmes Work experience, placements and internships Future leaders graduate programme Early talent Future leaders graduate programme Business operations Engineering Manufacturing Operations, Quality & Supply Chain Marketing and sales Research and development Technology Manufacturing Sciences & Technology Post graduate opportunities Veterans Our global and regional hubs How we hire Careers How we hire Frequently asked questions Fraudulent internet recruitment activities FEATURED SECTION Outstanding people FEATURED SECTION Diversity equity and inclusionHealthcare professionals Healthcare professionals Contact us Contact us Behind the science Prevention is the best medicine to stop disease before it starts We believe prevention is the best outcome, not just for patients but for the world’s health systems and economies. Read our article on prevention Close Video Our purpose We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. Our R&D focus is on four therapeutic areas: infectious diseases, HIV, immunology/respiratory and oncology Purpose, strategy and culture Why invest in GSK? Infectious diseases 1 in 6 deaths globally caused by infectious disease Go to infectious diseases HIV 39m people living with HIV globally Go to HIV Respiratory/Immunology 50yrs of leading research to help people with respiratory and inflammatory conditions Go to respiratory/immunology Oncology ~10m people died from cancer in 2020, making it a leading cause of death worldwide Go to oncology Behind the science Discover how we’re getting ahead ‘The roar I hear is the next stage of the rocket firing’: MAPS technology and the new age of vaccine development In the face of climate change, vaccines play a crucial but underestimated role Robots, AI, and machine learning: how smart manufacturing is getting medicines and vaccines from factories to patients faster ‘Three facts scientists have learned about RSV – and why sharing them could help protect those most at risk’ ’Prevention is the best medicine to stop disease before it starts’ A preventative patient-centred approach is key to transforming respiratory care and relieving struggling services ‘You can’t be what you can’t see’: Why diversity in STEM is key to greater medical innovation The ‘tripledemic’ will hit older people hard this winter – but there are things we can all do to reduce the impact Read our magazine Life at GSK How we help people thrive Culture At GSK, culture is something we all own. It’s powered by the little things GSK people do every day to help us get ahead of disease together. It drives delivery of our strategy and makes GSK a place people can thrive. Being ambitious for patients, accountable for impact and making sure we always do the right thing is how we deliver for patients, shareholders, and of course the people who work here. The Code Purpose, strategy and culture Growth Helping people grow professionally and personally is fundamental to GSK. Because we know when individuals grow, our company grows too. Everyone at GSK is encouraged to drive their development through a blend of on-the-job experiences, plus best-in-class formal and informal learning. Life at GSK Diversity, equity and inclusion We’re dedicated to diversity, equity and inclusion in what we do and how we do it. Because it’s the right thing to do and it helps us perform better. That’s why we focus on recognising and making the most of our differences and encourage everyone to bring their authentic selves to work. We make sure everyone gets equal opportunities and we’re fully committed to ensuring our workforce reflects the communities in which we work. Diversity, equity and inclusion Wellbeing We prioritise personal wellbeing so that our people can thrive both in and out of work. We achieve this by fostering a healthy and safe working space for them to succeed and grow. Above all, working at GSK means...
Domain Name: GSK.COM Registry Domain ID: 2466343_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.safenames.net Registrar URL: http://www.safenames.net Updated Date: 2023-09-21T15:40:09Z Creation Date: 1998-08-07T04:00:00Z Registry Expiry Date: 2024-08-06T04:00:00Z Registrar: SafeNames Ltd. Registrar IANA ID: 447 Registrar Abuse Contact Email: abuse@safenames.net Registrar Abuse Contact Phone: +44.1908200022 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Domain Status: serverDeleteProhibited https://icann.org/epp#serverDeleteProhibited Domain Status: serverTransferProhibited https://icann.org/epp#serverTransferProhibited Domain Status: serverUpdateProhibited https://icann.org/epp#serverUpdateProhibited Name Server: NS-1070.AWSDNS-05.ORG Name Server: NS-1601.AWSDNS-08.CO.UK Name Server: NS-87.AWSDNS-10.COM Name Server: NS-999.AWSDNS-60.NET DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T14:48:24Z <<<